Literature DB >> 21601051

Postexposure prophylaxis for rabies in resource-limited/poor countries.

Prapimporn Shantavasinkul1, Henry Wilde.   

Abstract

Human rabies is essentially a fatal disease once clinical signs develop. Rabies postexposure prophylaxis (PEP) consists of thorough wound care in combination with administration of rabies immunoglobulin and rabies vaccine. This is highly effective in rabies prevention if carried out diligently. Preexposure rabies prophylaxis simplifies PEP in the event of an exposure by eliminating the need for immunoglobulin. Shortened and more convenient and economical PEP regimens are being developed with promising results. They reduce the cost of PEP as well as travel expenses for the often very poor patients. The intradermal PEP regimen can now reduce the vaccine cost by ~60-70%. Although PEP in humans can prevent death, controlling the canine vector by sustained vaccination remains the mainstay of rabies elimination.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601051     DOI: 10.1016/B978-0-12-387040-7.00013-5

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  12 in total

Review 1.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Reducing Cost of Rabies Post Exposure Prophylaxis: Experience of a Tertiary Care Hospital in Pakistan.

Authors:  Naseem Salahuddin; M Aftab Gohar; Naila Baig-Ansari
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

3.  Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device.

Authors:  Waranyoo Phoolcharoen; Christophe Prehaud; Craig J van Dolleweerd; Leonard Both; Anaelle da Costa; Monique Lafon; Julian K-C Ma
Journal:  Plant Biotechnol J       Date:  2017-04-19       Impact factor: 9.803

4.  In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity.

Authors:  Waranyoo Phoolcharoen; Ashley C Banyard; Christophe Prehaud; David Selden; Guanghui Wu; Colin P D Birch; Tim H Szeto; Monique Lafon; Anthony R Fooks; Julian K-C Ma
Journal:  Vaccine       Date:  2018-03-06       Impact factor: 3.641

5.  Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.

Authors:  Tsepo Lebiletsa Tsekoa; Therese Lotter-Stark; Sindisiwe Buthelezi; Ereck Chakauya; Stoyan H Stoychev; Claude Sabeta; Wonderful Shumba; Baby Phahladira; Steve Hume; Josh Morton; Charles E Rupprecht; Herta Steinkellner; Michael Pauly; Larry Zeitlin; Kevin Whaley; Rachel Chikwamba
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

6.  Bites from the same dog, different outcomes for two patients: a case report.

Authors:  Xue-Yong Huang; Xing-Le Li; Shu-Yu Wu; Yu-Lei Gu; Xin-Jun Lv; John David Klena; Bian-Li Xu
Journal:  Infect Dis Poverty       Date:  2017-07-05       Impact factor: 4.520

7.  Dog Bites and Rabies in the Eastern Region of Ghana in 2013-2015: A Call for a One-Health Approach.

Authors:  Boakye-Yiadom Adomako; Frank Baiden; Samuel Sackey; Donne Kofi Ameme; Fred Wurapa; Kofi Mensah Nyarko; Ernest Kenu; Edwin Afari
Journal:  J Trop Med       Date:  2018-07-02

8.  Human rabies in Côte d'Ivoire 2014-2016: Results following reinforcements to rabies surveillance.

Authors:  Issaka Tiembré; Anaïs Broban; Joseph Bénié; Mathilde Tetchi; Sophie Druelles; Maïna L'Azou
Journal:  PLoS Negl Trop Dis       Date:  2018-09-06

9.  Retrospective Cohort Study to Assess the Risk of Rabies in Biting Dogs, 2013⁻2015, Republic of Haiti.

Authors:  Alexandra M Medley; Max Francois Millien; Jesse D Blanton; Xiaoyue Ma; Pierre Augustin; Kelly Crowdis; Ryan M Wallace
Journal:  Trop Med Infect Dis       Date:  2017-06-12

10.  Protection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines.

Authors:  Aurore Lebrun; Samantha Garcia; Jianwei Li; Rhonda B Kean; D Craig Hooper
Journal:  Trop Med Infect Dis       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.